← Back to Clinical Trials
Recruiting NCT05492175

NCT05492175 Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05492175
Status Recruiting
Phase
Sponsor Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Condition Stroke Rehabilitation
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2022-02-17
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
robotic practicekinetic exergamingconventional therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2022-02-17 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research program aims at investigating the effects of upper-limb robotic therapy primed with interactive exergaming as an innovative hybrid regimen in stroke rehabilitation.

Eligibility Criteria

Inclusion Criteria: 1. a first ever-stroke≧3 months 2. age range between 20 to 80 years 3. baseline Fugl-Meyer assessment of upper extremity scale (FMA-UE) between 18 to 56 4. no excessive muscle spasticity of the affected extremities (Modified Ashworth Scale \< 3 at any joints) 5. able to follow examiners' commands and study instructions (Mini-Mental State Examination score≧22) 6. can maintain a step-standing position for at least 30 seconds 7. can walk for at least 10 meters with or without device 8. no participation in further experimental rehabilitation or drug studies during the duration of the project Exclusion Criteria: 1. acute inflammation and pain 2. concomitant neurologic, neuromuscular or orthopedic conditions that may impede participation in this research.

Contact & Investigator

Central Contact

Keh-Chung Lin, Sc.D

✉ kehchunglin@ntu.edu.tw

📞 +886-3366-8180

Principal Investigator

Keh-Chung Lin, Sc.D

PRINCIPAL INVESTIGATOR

National Taiwan University

Frequently Asked Questions

Who can join the NCT05492175 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05492175 currently recruiting?

Yes, NCT05492175 is actively recruiting participants. Contact the research team at kehchunglin@ntu.edu.tw for enrollment information.

Where is the NCT05492175 trial being conducted?

This trial is being conducted at Taichung, Taiwan, Taipei, Taiwan, Taipei, Taiwan, Taipei, Taiwan.

Who is sponsoring the NCT05492175 clinical trial?

NCT05492175 is sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. The principal investigator is Keh-Chung Lin, Sc.D at National Taiwan University. The trial plans to enroll 72 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology